Impact of Medical Follow-up Discharge Package (RECALL-CT)

December 2, 2014 updated by: Jonathan Peter, University of Cape Town

A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa

The post discharge time is a vulnerable time for general medical in-patients, with high rates of adverse events that may cause unnecessary readmissions and even death. A recent study of 415 patients discharged from the general medical wards at Groote Schuur Hospital, demonstrated a very high 12 month mortality of 35%. The majority of these deaths were classified as "unexpected". The reasons for this were not further examined, but it was speculated, given the authors' knowledge of the public sector in Cape Town, that three related factors contribute significantly to this early mortality: i) a lack of continuity of care, with patients not necessarily accessing the primary care support treatment that they need or being able to access early post discharge follow-up (for example for anti-retroviral or anti-tuberculous care); ii) the inability of primary care to deal with the complex nature of the discharged patients, most whom have significant co-morbid disease; iii) A lack of optimisation of therapy for chronic disease after acute discharge.

The investigators hypothesise that an integrated post-discharge transitional care package, which includes an early medical specialist follow-up in the first 3 months after hospital discharge will decrease the 6- and 12-month mortality and re-admission rate amongst general medical hospital admissions in Cape Town, South Africa. Our study will compare an integrated package, suitable to implementation if effective, with current standard discharge packages.

Study Overview

Status

Withdrawn

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cape Town, South Africa, 8001
        • Groote Schuur Hospital
      • Cape Town, South Africa, 8001
        • Victoria Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients referred for admission to general medical wards (including within hospital transfer e.g. ICU discharge)
  2. >18 years and willing to give informed consent

Exclusion Criteria:

  1. Patient admitted directly to intensive care unit
  2. Patient refusing consent or <18 years old
  3. Patients electively admitted
  4. Patients without phone numbers who cannot provide any telephone contact details for a co-habitant, relative or neighbour.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Care
At discharge, patients will be given a discharge plan by their attending caregiver as deemed appropriate.
Other: Integrative medical follow-up package

At discharge, patients will receive a discharge plan by their attending caregiver.

Thereafter, if randomised to this study arm they will receive the intervention as outlined elsewhere.

"Integrated Medical Follow-up package"

At discharge, patients will receive a discharge plan by their attending caregiver.

  1. On day 3 they will be contacted telephonically to:

    i) Discuss their discharge diagnosis and medications ii) Arrange specialist clinic follow-up booking for 2 weeks iii) Reemphasise drug compliance

  2. Reminders via SMS to attend there OPD appointment(s)
  3. Medical out-patient review at 2-weeks and 6 weeks if required
  4. Medical telephonic "hot-line" for advice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cause mortality
Time Frame: 12 months
All cause 12-month mortality will be evaluated at 12-months post enrolment. Data on mortality will be acquired through telephonic patient/family contact and review of provincial death registry
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cause mortality
Time Frame: 6 months
6-month mortality will be evaluated in a similar way to 12-month mortality.
6 months
Hospital readmission rate
Time Frame: 12 months
Readmission to secondary, tertiary hospitals or emergency units will be included.
12 months
Bartel index
Time Frame: 12 months
The change in functional outcome between discharge and 12-months will be measured using the Bartel index.
12 months
Karnofsky performance score
Time Frame: 12 months
Changes in functional outcomes will be assessed by measuring the change in Karnofsky performance scores between 12-months and pre-admission.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonathan Peter, University of Cape Town

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Anticipated)

December 1, 2015

Study Completion (Anticipated)

May 1, 2016

Study Registration Dates

First Submitted

August 1, 2013

First Submitted That Met QC Criteria

August 5, 2013

First Posted (Estimate)

August 6, 2013

Study Record Updates

Last Update Posted (Estimate)

December 3, 2014

Last Update Submitted That Met QC Criteria

December 2, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • UCT 148.2/2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Follow-up Study

Clinical Trials on Integrated medical follow-up package

3
Subscribe